Dashavatar puts Marathi cinema on global map as Dilip Prabhavalkar starrer becomes first Marathi film to enter Oscar Contention List |

In a major milestone for regional Indian cinema, Marathi feature film Dashavatar, which stars Dilip Prabhavalkar, Priyadarshini Indalkar, Sidhharth Menon, Mahesh Manjrekar among others, has been officially selected in the Oscar Contention List for the upcoming Academy Awards. The selection places the film among a highly exclusive group of global titles being considered for the…

Read More

Basal cell skin cancer: Dermatologist explains how it can be mistaken for a harmless pimple and shares how to identify the difference |

Basal cell skin cancer can be easily mistaken for something so harmless as a pimple. This is why understanding even the most subtle signs can be life saving. Highlighting the same, board-certified dermatologist Jenny Liu shared an Instagram video and explained how one of the most malignant cancers can disguise itself as a minor skin…

Read More

KKR drops Mustafizur Rahman: Politics erupts over Bangladesh player in IPL; opposition targets BCCI | India News

Congress MP Shashi Tharoor, left, Mustafizur Rahman, middle, and BJP leader Sangeet Som NEW DELHI: Kolkata Knight Riders (KKR) on Saturday released Bangladeshi fast bowler Mustafizur Rahman from their IPL 2026 squad following a directive from the Board of Control for Cricket in India (BCCI).KKR had picked Mustafizur Rahman for Rs 9.20 crore at the…

Read More

‘What will we say now if Putin tries to capture Zelenskyy’: Indian-origin Ro Khanna says Trump’s strike on Venezuela is a ‘war of choice’

Indian-origin Democrat Congressman Ro Khanna condemned President Donald Trump’s military strike on Venezuela and said Trump bowed to a foreign policy blob committed to militarism. “What will we say now if Xi Jinping wants to capture Lai of Taiwan or Putin tries to capture Zelensky in Ukraine?” Khanna said, adding that Trump betrayed his MAGA…

Read More

Pharma generics: Semaglutide patent expiry to open Rs 50-billion opportunity; Indian players eye FY27 boost

The impending patent expiry of semaglutide drugs across India, emerging markets and select regulated markets such as Canada and Brazil is expected to create a revenue opportunity of more than Rs 50 billion for generic pharmaceutical companies over the next 12 to 15 months, according to an industry update by Systematix Institutional Research.The report said…

Read More